Podium to Practice: ASH® 2025 – LYMPHOMA: A real-world study from the DESCAR-T registry
OR
Please enter your username or email address. You will receive an email message to log in.
Explore more from your favourite experts – click their name to access their entire library of content.
Chair
Speakers
Studies / Trials Discussed
ID 1012 – CAR T-cell therapy in secondary CNS lymphomas: A real-world study from the descar-t registry
This program has been made possible through unrestricted support from Eli Lilly and Merck.
Studies/trials discussed:
ID 1012 – CAR T-cell therapy in secondary CNS lymphomas: A real-world study from the descar-t registry
©2026 OncologyEducation a Think Research company. All rights reserved. Privacy Policy. Privacy Notice. Accessibility Statement. Cookies Policy.
Pre-Video Survey
By continuing to watch the video, you consent to receiving a post-view survey by email.